Answers are grounded in this paper and cite their sources.
In recent years, the use of gonadotropin-releasing hormone (GnRH) analogues in adolescents with gender dysphoria (GD) to suppress puberty has been adopted by an increasing number of gender clinics, generating controversial debate. This short essay provides an overview of the difficulties associated with this heterogeneous group of adolescents and discusses arguments for and against the suspension of puberty. Further, it reviews the main follow-up studies conducted in some of the world's largest clinical centres for gender-variant children and adolescents.
No takes yet. Share an insight, caveat, or question.
Guido Giovanardi (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: